Compare CLMB & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLMB | DNA |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | United States |
| Employees | N/A | 485 |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.8M | 455.8M |
| IPO Year | 1996 | N/A |
| Metric | CLMB | DNA |
|---|---|---|
| Price | $19.59 | $5.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $30.00 | $8.50 |
| AVG Volume (30 Days) | 102.6K | ★ 1.2M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ 4.64 | N/A |
| Revenue | ★ $652,517,000.00 | N/A |
| Revenue This Year | $4.15 | N/A |
| Revenue Next Year | $5.21 | N/A |
| P/E Ratio | $4.31 | ★ N/A |
| Revenue Growth | ★ 40.14 | N/A |
| 52 Week Low | $19.45 | $5.00 |
| 52 Week High | $145.00 | $17.58 |
| Indicator | CLMB | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 8.43 | 36.90 |
| Support Level | N/A | N/A |
| Resistance Level | $113.14 | $10.05 |
| Average True Range (ATR) | 2.65 | 0.47 |
| MACD | -5.96 | 0.04 |
| Stochastic Oscillator | 0.47 | 5.07 |
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.